Machiel Van Der Leest

Machiel Van Der Leest has held a variety of roles in the medical industry since 1999. Machiel began their career as the Director of R&D at Cathnet Science in 1999. Machiel then moved to Minvasys in 2003, where they held the same role. In 2008, they became the CEO of Arterial Remodeling Technologies (ART). Most recently, they have been the CEO of GUARD MEDICAL since 2019.

Machiel Van Der Leest obtained a Master of Science (MSc) in Industrial Design Engineering from Delft University of Technology between 1991 and 1996.